These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25416811)

  • 1. How can we solve the enigma of influenza vaccine-induced protection?
    Neuzil KM
    J Infect Dis; 2015 May; 211(10):1517-8. PubMed ID: 25416811
    [No Abstract]   [Full Text] [Related]  

  • 2. Influenza vaccine in the red zone defense: a game-day player.
    Peters TR; Poehling KA
    J Infect Dis; 2014 Sep; 210(5):671-3. PubMed ID: 24676206
    [No Abstract]   [Full Text] [Related]  

  • 3. Pandemic influenza vaccine policy--considering the early evidence.
    Neuzil KM
    N Engl J Med; 2009 Dec; 361(25):e59. PubMed ID: 19745213
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influenza vaccination? An extra vaccine for seniors?].
    MMW Fortschr Med; 2003 Sep; 145(37):61. PubMed ID: 14584449
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccines against avian influenza--a race against time.
    Poland GA
    N Engl J Med; 2006 Mar; 354(13):1411-3. PubMed ID: 16571885
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunogenicity and protective efficacy of influenza vaccination.
    Hannoun C; Megas F; Piercy J
    Virus Res; 2004 Jul; 103(1-2):133-8. PubMed ID: 15163501
    [No Abstract]   [Full Text] [Related]  

  • 7. Intranasal influenzavirus vaccine in children.
    Edwards KM; Dupont WD
    N Engl J Med; 1998 Sep; 339(13):922; author reply 922-3. PubMed ID: 9750091
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlates of vaccine protection from influenza and its complications.
    McCullers JA; Huber VC
    Hum Vaccin Immunother; 2012 Jan; 8(1):34-44. PubMed ID: 22252001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvanted or whole-virion vaccine for 2009 influenza A (H1N1).
    Barrett PN; Ehrlich HJ
    Lancet Infect Dis; 2011 Jul; 11(7):496-7; author reply 497-8. PubMed ID: 21700237
    [No Abstract]   [Full Text] [Related]  

  • 10. Influenza vaccination with 1/10th the full dose.
    Cooper CL; Davis H; Cameron DW
    N Engl J Med; 2004 Nov; 351(22):2339-40. PubMed ID: 15564552
    [No Abstract]   [Full Text] [Related]  

  • 11. Influenza vaccine--for whom?
    Haneberg B; Mamelund SE; Mjaaland S
    Tidsskr Nor Laegeforen; 2013 Nov; 133(22):2376-8. PubMed ID: 24287838
    [No Abstract]   [Full Text] [Related]  

  • 12. Influenza vaccine for children.
    Neuzil KM
    Clin Infect Dis; 2004 Mar; 38(5):689-91. PubMed ID: 14986253
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age.
    Baxter R; Patriarca PA; Ensor K; Izikson R; Goldenthal KL; Cox MM
    Vaccine; 2011 Mar; 29(12):2272-8. PubMed ID: 21277410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza, influenza virus vaccine, and human immunodeficiency virus infection.
    Couch RB
    Clin Infect Dis; 1999 Mar; 28(3):548-51. PubMed ID: 10194076
    [No Abstract]   [Full Text] [Related]  

  • 15. Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibility.
    Ohmit SE; Petrie JG; Malosh RE; Fry AM; Thompson MG; Monto AS
    J Infect Dis; 2015 May; 211(10):1519-28. PubMed ID: 25416812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influenza vaccination. Waiting for the holy grail].
    MMW Fortschr Med; 2013 Mar; 155(4):21. PubMed ID: 23614186
    [No Abstract]   [Full Text] [Related]  

  • 17. A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity.
    Lu CC; Wang YC; Lai JH; Lee TS; Lin HT; Chang DM
    Vaccine; 2011 Jan; 29(3):444-50. PubMed ID: 21078406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza immunology evaluation and correlates of protection: a focus on vaccines.
    Trombetta CM; Montomoli E
    Expert Rev Vaccines; 2016 Aug; 15(8):967-76. PubMed ID: 26954563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunogenicity and safety of domestic slit influenza vaccine].
    Zhu XJ; Zhang ZL; Li H; Su X; Guo XH; Chen W; Kou M; Duan WP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jul; 25(7):644. PubMed ID: 15308057
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunological effectiveness of a method for simultaneous immunization against influenza using live and inactivated vaccines].
    Orlov VA; Zhilova GP; Ignat'eva GS; Malikova EV; Efremov BV
    Vopr Virusol; 1982; 27(3):271-5. PubMed ID: 7123907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.